Alpha Preclinical

About Us

Alpha Preclinical (Alpha) formed in 2020 and is a US owned company. We are a discovery preclinical research service company designed to address the rapid and expansive growth demand of the discovery preclinical research sector.

The life-science research community is being challenged to accelerate therapies into the market with better operational efficiency. Outsourcing preclinical research needs, allows companies to focus on their core competencies and reduce time to market.

Alpha bridges our client's needs to reach the clinic and harnessing our expertise using a personalized interface approach.

Our goal is to strategically partner with our clients by reliably providing well-executed and cost-effective studies conducted in a timely manner to support their innovative drug development and research programs.

Trust. Trust is the key to Alpha’s team building and long-term relationships with clients. We achieve trust through honest and open discussions to attain a common goal, SUCCESS. This mutual trust keeps the team unified and focused on goals and meeting objectives.

Innovation. Alpha’s team is comprised of innovative employees and scientists who bring decades of expertise in all aspects of preclinical research.

Transparency. Transparency is the keystone to trust. Alpha believes it is essential that all operational and study details are communicated clearly and in timely manner to clients.

Customer-Centric. Alpha is a service company that strives to provide our clients with a seamless experience for their research program. Alpha does our utmost to generate long lasting business value for our clients knowing, we create customer value, by placing the client first.